CAMP and atherosclerosis: In addition, although we showed that the presence of LL37 promoted the development of atherosclerosis in mice, the role of LL37 in the development of human atherosclerotic plaque has yet to be determined, since several aspects of the pathogenesis of atherosclerosis differ between humans and mice (79, 80).